Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.56% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -38.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.61% |
| Mar 31, 2026 | -38.56% |
| Sep 30, 2025 | 34.15% |
| Jun 30, 2025 | -42.56% |
| Mar 31, 2025 | 1,011.12% |
| Dec 31, 2024 | 4.85% |
| Sep 30, 2024 | 15.00% |
| Jun 30, 2024 | 90.78% |
| Mar 31, 2024 | -89.18% |
| Dec 31, 2023 | 260.36% |
| Sep 30, 2023 | 10.88% |
| Jun 30, 2023 | -74.68% |
| Mar 31, 2023 | 17.03% |
| Dec 31, 2022 | -46.48% |
| Sep 30, 2022 | -289.80% |
| Jun 30, 2022 | 516.98% |
| Mar 31, 2022 | 39.88% |
| Sep 30, 2021 | -679.03% |
| Jun 30, 2021 | 312.14% |
| Mar 31, 2021 | -18.39% |